AI IS ACCELERATING THE PATH TO NEW MEDICINES
GET THE FAST FACTS - AND NOT THE HYPE
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
$0.00 por los primeros 30 días
AI IS ACCELERATING THE PATH TO NEW MEDICINES
Compra ahora por $7.00
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
-
Narrado por:
-
Virtual Voice
-
De:
-
Richard Murch
Este título utiliza narración de voz virtual
Acerca de esta escucha
Traditionally, developing new drugs has been a slow and expensive process. AI is changing that by streamlining every stage. From analyzing vast amounts of scientific data to designing new molecules, AI can pinpoint promising drug candidates much faster than traditional methods. This increases the success rate of clinical trials, which are notoriously high-risk endeavors.
One example of this progress is a recent study where AI-generated molecules advanced to Phase II clinical trials. This signifies a major breakthrough because it demonstrates AI's ability to not only identify targets but also design entirely new drugs from scratch. This opens doors for personalized medicine, where drugs can be tailored to a patient's specific needs.
The future of AI in medicine looks promising. While AI won't replace human researchers entirely, it acts as a powerful tool that can accelerate discoveries and usher in a new era of effective treatments.